25 XP   0   0   10

Zhejiang Jolly Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Jolly Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Jolly Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Jolly Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Jolly Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jolly Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Jolly Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Jolly Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.11
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.93
Expected worth in 1 year
¥8.36
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥5.26
Return On Investment
36.3%

For what price can you sell your share?

Current Price per Share
¥14.50
Expected price per share
¥13.70 - ¥15.20
How sure are you?
50%

1. Valuation of Zhejiang Jolly Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥14.50

Intrinsic Value Per Share

¥1.12 - ¥5.19

Total Value Per Share

¥5.05 - ¥9.13

2. Growth of Zhejiang Jolly Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Jolly Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$381.4m$274m$107.3m28.1%

How much money is Zhejiang Jolly Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$37.7m$24.7m$12.9m34.3%
Net Profit Margin15.1%12.3%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Jolly Pharmaceutical Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#147 / 1016

Most Revenue
#58 / 1016

Most Profit
#61 / 1016

Most Efficient
#93 / 1016

What can you expect buying and holding a share of Zhejiang Jolly Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Jolly Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Jolly Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Jolly Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Jolly Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Jolly Pharmaceutical Co Ltd is ¥14.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Jolly Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Jolly Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.93. Based on the TTM, the Book Value Change Per Share is ¥1.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.38 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Jolly Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.050.4%0.050.4%0.040.2%0.020.2%0.020.1%
Usd Book Value Change Per Share0.151.1%0.151.1%0.050.4%0.050.3%0.040.3%
Usd Dividend Per Share0.030.2%0.030.2%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.181.3%0.181.3%0.070.5%0.060.4%0.050.4%
Usd Price Per Share1.47-1.47-1.61-1.06-1.48-
Price to Earnings Ratio27.41-27.41-45.58-86.55-105.97-
Price-to-Total Gains Ratio8.12-8.12-24.48-6.56-48.91-
Price to Book Ratio2.71-2.71-4.12-2.87-6.29-
Price-to-Total Gains Ratio8.12-8.12-24.48-6.56-48.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.0039
Number of shares499
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.150.05
Usd Total Gains Per Share0.180.06
Gains per Quarter (499 shares)90.6431.81
Gains per Year (499 shares)362.56127.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15730535327100117
211461171655200244
3171916107982300371
422812221442109399498
528515271805137499625
634318332168164599752
740021382531192699879
8457244428942197991006
9514274932572468991133
10571305536202749991260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%15.01.00.093.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.03.081.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%15.01.00.093.8%

Fundamentals of Zhejiang Jolly Pharmaceutical Co Ltd

About Zhejiang Jolly Pharmaceutical Co Ltd

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. Zhejiang Jolly Pharmaceutical Co.,LTD was founded in 1995 and is based in Huzhou, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-16 12:53:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Zhejiang Jolly Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Jolly Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 15.1% means that ¥0.15 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 15.1%. The company is making a huge profit. +2
  • The TTM is 15.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.1%TTM15.1%0.0%
TTM15.1%YOY12.3%+2.8%
TTM15.1%5Y8.2%+6.9%
5Y8.2%10Y10.7%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.1%-197.2%+212.3%
TTM15.1%-210.4%+225.5%
YOY12.3%-279.3%+291.6%
5Y8.2%-436.8%+445.0%
10Y10.7%-599.3%+610.0%
1.1.2. Return on Assets

Shows how efficient Zhejiang Jolly Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 7.5% Return on Assets means that Zhejiang Jolly Pharmaceutical Co Ltd generated ¥0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 7.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.5%0.0%
TTM7.5%YOY6.5%+1.0%
TTM7.5%5Y4.0%+3.5%
5Y4.0%10Y4.7%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%-13.6%+21.1%
TTM7.5%-12.9%+20.4%
YOY6.5%-11.9%+18.4%
5Y4.0%-14.2%+18.2%
10Y4.7%-16.2%+20.9%
1.1.3. Return on Equity

Shows how efficient Zhejiang Jolly Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • 10.1% Return on Equity means Zhejiang Jolly Pharmaceutical Co Ltd generated ¥0.10 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 10.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY9.7%+0.4%
TTM10.1%5Y5.8%+4.3%
5Y5.8%10Y6.8%-1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%-17.0%+27.1%
TTM10.1%-16.1%+26.2%
YOY9.7%-15.4%+25.1%
5Y5.8%-20.0%+25.8%
10Y6.8%-21.1%+27.9%

1.2. Operating Efficiency of Zhejiang Jolly Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Jolly Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Jolly Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 17.8% means the company generated ¥0.18  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 17.8%. The company is operating efficient. +1
  • The TTM is 17.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.8%TTM17.8%0.0%
TTM17.8%YOY15.4%+2.4%
TTM17.8%5Y10.9%+7.0%
5Y10.9%10Y9.3%+1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.8%-286.1%+303.9%
TTM17.8%-224.4%+242.2%
YOY15.4%-288.4%+303.8%
5Y10.9%-475.2%+486.1%
10Y9.3%-624.7%+634.0%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Jolly Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are ¥1.10 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 1.102. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.102. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.102TTM1.1020.000
TTM1.102YOY1.122-0.021
TTM1.1025Y1.197-0.096
5Y1.19710Y1.008+0.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1022.997-1.895
TTM1.1023.247-2.145
YOY1.1223.766-2.644
5Y1.1975.675-4.478
10Y1.0087.857-6.849

1.3. Liquidity of Zhejiang Jolly Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Jolly Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.60 means the company has ¥2.60 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 2.596. The company is able to pay all its short-term debts. +1
  • The TTM is 2.596. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.596TTM2.5960.000
TTM2.596YOY1.611+0.985
TTM2.5965Y1.732+0.863
5Y1.73210Y1.625+0.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5963.930-1.334
TTM2.5964.251-1.655
YOY1.6115.436-3.825
5Y1.7326.045-4.313
10Y1.6256.363-4.738
1.3.2. Quick Ratio

Measures if Zhejiang Jolly Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.61 means the company can pay off ¥0.61 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 0.614. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.614. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.614TTM0.6140.000
TTM0.614YOY0.735-0.121
TTM0.6145Y0.644-0.029
5Y0.64410Y0.813-0.170
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6143.629-3.015
TTM0.6144.065-3.451
YOY0.7355.397-4.662
5Y0.6445.993-5.349
10Y0.8136.277-5.464

1.4. Solvency of Zhejiang Jolly Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Jolly Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Zhejiang Jolly Pharmaceutical Co Ltd assets are financed with 24.2% credit (debt) and the remaining percentage (100% - 24.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 0.242. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.242. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.2420.000
TTM0.242YOY0.278-0.037
TTM0.2425Y0.296-0.055
5Y0.29610Y0.273+0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2420.332-0.090
TTM0.2420.334-0.092
YOY0.2780.268+0.010
5Y0.2960.366-0.070
10Y0.2730.390-0.117
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Jolly Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 32.5% means that company has ¥0.33 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The MRQ is 0.325. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.325. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.325TTM0.3250.000
TTM0.325YOY0.415-0.090
TTM0.3255Y0.452-0.127
5Y0.45210Y0.410+0.042
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3250.381-0.056
TTM0.3250.390-0.065
YOY0.4150.334+0.081
5Y0.4520.434+0.018
10Y0.4100.466-0.056

2. Market Valuation of Zhejiang Jolly Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Jolly Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Jolly Pharmaceutical Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 27.41 means the investor is paying ¥27.41 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The EOD is 37.252. Based on the earnings, the company is overpriced. -1
  • The MRQ is 27.413. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.413. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD37.252MRQ27.413+9.840
MRQ27.413TTM27.4130.000
TTM27.413YOY45.584-18.172
TTM27.4135Y86.547-59.135
5Y86.54710Y105.965-19.418
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD37.252-2.315+39.567
MRQ27.413-2.560+29.973
TTM27.413-2.664+30.077
YOY45.584-4.122+49.706
5Y86.547-6.258+92.805
10Y105.965-6.108+112.073
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The EOD is 72.356. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 53.244. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 53.244. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD72.356MRQ53.244+19.112
MRQ53.244TTM53.2440.000
TTM53.244YOY78.754-25.510
TTM53.2445Y28.556+24.688
5Y28.55610Y307.033-278.477
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD72.356-3.067+75.423
MRQ53.244-3.251+56.495
TTM53.244-3.545+56.789
YOY78.754-5.595+84.349
5Y28.556-8.315+36.871
10Y307.033-8.708+315.741
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Jolly Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.71 means the investor is paying ¥2.71 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Jolly Pharmaceutical Co Ltd:

  • The EOD is 3.685. Based on the equity, the company is fair priced.
  • The MRQ is 2.712. Based on the equity, the company is underpriced. +1
  • The TTM is 2.712. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.685MRQ2.712+0.973
MRQ2.712TTM2.7120.000
TTM2.712YOY4.124-1.412
TTM2.7125Y2.874-0.163
5Y2.87410Y6.293-3.418
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.6851.905+1.780
MRQ2.7122.111+0.601
TTM2.7122.095+0.617
YOY4.1242.836+1.288
5Y2.8743.443-0.569
10Y6.2933.794+2.499
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Jolly Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.1071.1070%0.376+194%0.362+206%0.293+278%
Book Value Per Share--3.9353.9350%2.828+39%2.640+49%2.181+80%
Current Ratio--2.5962.5960%1.611+61%1.732+50%1.625+60%
Debt To Asset Ratio--0.2420.2420%0.278-13%0.296-18%0.273-12%
Debt To Equity Ratio--0.3250.3250%0.415-22%0.452-28%0.410-21%
Dividend Per Share--0.2070.2070%0.100+107%0.099+109%0.092+126%
Eps--0.3890.3890%0.256+52%0.168+132%0.139+180%
Free Cash Flow Per Share--0.2000.2000%0.148+35%0.136+47%0.047+330%
Free Cash Flow To Equity Per Share--1.1171.1170%-0.198+118%0.164+583%0.125+791%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.193--------
Intrinsic Value_10Y_min--1.119--------
Intrinsic Value_1Y_max--0.286--------
Intrinsic Value_1Y_min--0.064--------
Intrinsic Value_3Y_max--1.039--------
Intrinsic Value_3Y_min--0.235--------
Intrinsic Value_5Y_max--2.006--------
Intrinsic Value_5Y_min--0.451--------
Market Cap10170111616.000+26%7483802864.4507483802864.4500%8178172513.280-8%5393666789.338+39%7497855519.9090%
Net Profit Margin--0.1510.1510%0.123+23%0.082+83%0.107+41%
Operating Margin--0.1780.1780%0.154+16%0.109+64%0.093+91%
Operating Ratio--1.1021.1020%1.122-2%1.197-8%1.008+9%
Pb Ratio3.685+26%2.7122.7120%4.124-34%2.874-6%6.293-57%
Pe Ratio37.252+26%27.41327.4130%45.584-40%86.547-68%105.965-74%
Price Per Share14.500+26%10.67010.6700%11.660-8%7.690+39%10.6900%
Price To Free Cash Flow Ratio72.356+26%53.24453.2440%78.754-32%28.556+86%307.033-83%
Price To Total Gains Ratio11.032+26%8.1188.1180%24.482-67%6.561+24%48.909-83%
Quick Ratio--0.6140.6140%0.735-16%0.644-5%0.813-24%
Return On Assets--0.0750.0750%0.065+15%0.040+89%0.047+58%
Return On Equity--0.1010.1010%0.097+4%0.058+75%0.068+49%
Total Gains Per Share--1.3141.3140%0.476+176%0.461+185%0.385+242%
Usd Book Value--381421663.769381421663.7690%274080720.819+39%255882297.487+49%211443111.076+80%
Usd Book Value Change Per Share--0.1530.1530%0.052+194%0.050+206%0.040+278%
Usd Book Value Per Share--0.5440.5440%0.391+39%0.365+49%0.301+80%
Usd Dividend Per Share--0.0290.0290%0.014+107%0.014+109%0.013+126%
Usd Eps--0.0540.0540%0.035+52%0.023+132%0.019+180%
Usd Free Cash Flow--19424905.80019424905.8000%14351376.225+35%13228091.956+47%4518720.121+330%
Usd Free Cash Flow Per Share--0.0280.0280%0.020+35%0.019+47%0.006+330%
Usd Free Cash Flow To Equity Per Share--0.1540.1540%-0.027+118%0.023+583%0.017+791%
Usd Market Cap1405509425.331+26%1034261555.8671034261555.8670%1130223441.335-8%745404750.287+39%1036203632.8510%
Usd Price Per Share2.004+26%1.4751.4750%1.611-8%1.063+39%1.4770%
Usd Profit--37729519.38437729519.3840%24794198.205+52%16240189.718+132%13456213.904+180%
Usd Revenue--249472471.552249472471.5520%201412136.379+24%165697826.042+51%127610590.673+95%
Usd Total Gains Per Share--0.1820.1820%0.066+176%0.064+185%0.053+242%
 EOD+4 -4MRQTTM+0 -0YOY+30 -55Y+32 -310Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Jolly Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1537.252
Price to Book Ratio (EOD)Between0-13.685
Net Profit Margin (MRQ)Greater than00.151
Operating Margin (MRQ)Greater than00.178
Quick Ratio (MRQ)Greater than10.614
Current Ratio (MRQ)Greater than12.596
Debt to Asset Ratio (MRQ)Less than10.242
Debt to Equity Ratio (MRQ)Less than10.325
Return on Equity (MRQ)Greater than0.150.101
Return on Assets (MRQ)Greater than0.050.075
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Jolly Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.847
Ma 20Greater thanMa 5013.028
Ma 50Greater thanMa 10011.749
Ma 100Greater thanMa 20011.122
OpenGreater thanClose13.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,639,118
Total Liabilities879,193
Total Stockholder Equity2,703,750
 As reported
Total Liabilities 879,193
Total Stockholder Equity+ 2,703,750
Total Assets = 3,639,118

Assets

Total Assets3,639,118
Total Current Assets1,959,542
Long-term Assets1,679,576
Total Current Assets
Cash And Cash Equivalents 1,082,071
Short-term Investments 10,828
Net Receivables 452,840
Inventory 318,826
Other Current Assets 5,448
Total Current Assets  (as reported)1,959,542
Total Current Assets  (calculated)1,870,013
+/- 89,529
Long-term Assets
Property Plant Equipment 972,414
Goodwill 130,319
Intangible Assets 63,961
Other Assets 121,446
Long-term Assets  (as reported)1,679,576
Long-term Assets  (calculated)1,288,139
+/- 391,438

Liabilities & Shareholders' Equity

Total Current Liabilities754,940
Long-term Liabilities124,253
Total Stockholder Equity2,703,750
Total Current Liabilities
Short Long Term Debt 138,157
Accounts payable 468,883
Other Current Liabilities 66,735
Total Current Liabilities  (as reported)754,940
Total Current Liabilities  (calculated)673,776
+/- 81,164
Long-term Liabilities
Other Liabilities 92,122
Deferred Long Term Liability 25,419
Long-term Liabilities  (as reported)124,253
Long-term Liabilities  (calculated)117,540
+/- 6,713
Total Stockholder Equity
Common Stock701,387
Retained Earnings 676,802
Other Stockholders Equity 190,191
Total Stockholder Equity (as reported)2,703,750
Total Stockholder Equity (calculated)1,568,381
+/- 1,135,369
Other
Capital Stock701,387
Common Stock Shares Outstanding 701,387
Net Invested Capital 2,851,907
Net Tangible Assets 2,510,395
Net Working Capital 1,204,602
Property Plant and Equipment Gross 972,414



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
251,253
279,873
297,769
348,644
843,908
864,187
941,897
1,181,516
1,850,547
2,037,850
2,152,431
2,113,803
2,050,646
2,469,876
2,748,532
3,639,118
3,639,1182,748,5322,469,8762,050,6462,113,8032,152,4312,037,8501,850,5471,181,516941,897864,187843,908348,644297,769279,873251,253
   > Total Current Assets 
0
0
0
0
0
0
0
0
1,102,498
1,009,043
933,784
888,351
690,910
965,376
941,671
1,959,542
1,959,542941,671965,376690,910888,351933,7841,009,0431,102,49800000000
       Cash And Cash Equivalents 
14,321
19,326
29,750
44,750
424,345
368,513
357,834
249,313
450,215
330,219
168,755
220,455
138,414
253,746
232,303
1,082,071
1,082,071232,303253,746138,414220,455168,755330,219450,215249,313357,834368,513424,34544,75029,75019,32614,321
       Short-term Investments 
0
0
0
0
0
0
0
0
219,126
151,500
106,000
3,188
300
61,042
65,518
10,828
10,82865,51861,0423003,188106,000151,500219,12600000000
       Net Receivables 
59,660
69,467
65,818
57,551
82,488
75,241
114,838
213,646
227,926
307,385
318,368
384,391
338,220
271,860
364,100
452,840
452,840364,100271,860338,220384,391318,368307,385227,926213,646114,83875,24182,48857,55165,81869,46759,660
       Other Current Assets 
4,516
4,764
189
4,454
4,365
2,498
2,378
12,138
6,671
9,555
75,099
34,053
12,709
135,071
6,162
5,448
5,4486,162135,07112,70934,05375,0999,5556,67112,1382,3782,4984,3654,4541894,7644,516
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
1,028,807
1,218,647
1,225,452
1,359,736
1,504,501
1,806,861
1,679,576
1,679,5761,806,8611,504,5011,359,7361,225,4521,218,6471,028,807000000000
       Property Plant Equipment 
119,929
140,077
149,555
202,897
291,401
367,991
388,664
465,189
486,962
584,297
698,882
755,835
799,018
750,092
806,325
972,414
972,414806,325750,092799,018755,835698,882584,297486,962465,189388,664367,991291,401202,897149,555140,077119,929
       Goodwill 
0
0
0
0
0
0
0
100,255
161,000
161,000
152,071
140,592
130,319
130,319
130,319
130,319
130,319130,319130,319130,319140,592152,071161,000161,000100,2550000000
       Long Term Investments 
0
0
0
0
0
0
0
0
23,860
179,480
251,950
167,972
0
0
0
0
0000167,972251,950179,48023,86000000000
       Intangible Assets 
35,098
34,035
34,392
19,993
17,944
21,164
20,043
142,334
45,672
75,381
76,447
79,580
74,902
70,195
64,888
63,961
63,96164,88870,19574,90279,58076,44775,38145,672142,33420,04321,16417,94419,99334,39234,03535,098
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
1,617
11,125
51,784
93,707
53,374
113,549
74,758
74,758113,54953,37493,70751,78411,1251,617000000000
> Total Liabilities 
106,785
130,762
132,074
141,472
159,991
158,268
169,380
309,754
414,943
565,998
662,056
726,501
642,858
750,429
765,314
879,193
879,193765,314750,429642,858726,501662,056565,998414,943309,754169,380158,268159,991141,472132,074130,762106,785
   > Total Current Liabilities 
104,935
125,552
76,864
91,439
118,697
122,395
153,011
242,129
321,661
420,687
528,493
593,982
512,402
599,043
584,575
754,940
754,940584,575599,043512,402593,982528,493420,687321,661242,129153,011122,395118,69791,43976,864125,552104,935
       Short-term Debt 
0
0
0
0
0
0
0
0
1,590
224,000
254,000
337,318
0
0
0
0
0000337,318254,000224,0001,59000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
1,590
224,000
254,000
337,318
216,819
302,849
178,196
138,157
138,157178,196302,849216,819337,318254,000224,0001,59000000000
       Accounts payable 
5,651
26,388
14,521
13,268
23,791
22,781
25,271
57,685
51,850
93,883
152,160
123,601
181,351
200,633
296,769
468,883
468,883296,769200,633181,351123,601152,16093,88351,85057,68525,27122,78123,79113,26814,52126,3885,651
       Other Current Liabilities 
20,884
9,664
12,843
19,171
23,906
26,314
32,820
78,404
53,399
41,426
62,882
93,549
21,312
30,691
43,069
66,735
66,73543,06930,69121,31293,54962,88241,42653,39978,40432,82026,31423,90619,17112,8439,66420,884
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
145,311
133,563
132,519
130,455
151,387
180,739
124,253
124,253180,739151,387130,455132,519133,563145,311000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-1,590
-224,000
-254,000
-337,318
0
27,316
24,268
22,131
22,13124,26827,3160-337,318-254,000-224,000-1,59000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
121,000
109,500
104,000
88,134
0
0
0
00088,134104,000109,500121,000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
24,661
23,411
22,923
24,621
24,716
23,108
25,598
25,419
25,41925,59823,10824,71624,62122,92323,41124,66100000000
> Total Stockholder Equity
144,468
149,111
165,695
207,172
683,917
705,920
772,517
803,701
1,291,690
1,321,715
1,354,667
1,291,564
1,310,354
1,602,813
1,844,064
2,703,750
2,703,7501,844,0641,602,8131,310,3541,291,5641,354,6671,321,7151,291,690803,701772,517705,920683,917207,172165,695149,111144,468
   Common Stock
120,000
60,000
60,000
60,000
80,000
144,000
144,000
316,800
608,625
608,625
608,625
608,625
608,625
608,625
608,625
701,387
701,387608,625608,625608,625608,625608,625608,625608,625316,800144,000144,00080,00060,00060,00060,000120,000
   Retained Earnings 
15,388
18,641
33,561
71,880
118,660
135,570
195,967
250,284
271,697
301,114
334,081
342,661
319,563
396,193
525,520
676,802
676,802525,520396,193319,563342,661334,081301,114271,697250,284195,967135,570118,66071,88033,56118,64115,388
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
41,887
257,520
369,444
190,191
190,191369,444257,52041,887000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,925,700
Cost of Revenue-605,336
Gross Profit1,320,3641,320,364
 
Operating Income (+$)
Gross Profit1,320,364
Operating Expense-1,501,945
Operating Income423,755-181,581
 
Operating Expense (+$)
Research Development72,112
Selling General Administrative836,789
Selling And Marketing Expenses-
Operating Expense1,501,945908,902
 
Net Interest Income (+$)
Interest Income12,309
Interest Expense-7,907
Other Finance Cost-6,721
Net Interest Income11,123
 
Pretax Income (+$)
Operating Income423,755
Net Interest Income11,123
Other Non-Operating Income Expenses-
Income Before Tax (EBT)418,885423,755
EBIT - interestExpense = -7,907
355,912
363,819
Interest Expense7,907
Earnings Before Interest and Taxes (EBIT)-426,793
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax418,885
Tax Provision-55,377
Net Income From Continuing Ops363,508363,508
Net Income355,912
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--11,123
 

Technical Analysis of Zhejiang Jolly Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Jolly Pharmaceutical Co Ltd. The general trend of Zhejiang Jolly Pharmaceutical Co Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Jolly Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Jolly Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.20.

The bearish price targets are: 13.91 > 13.74 > 13.70.

Tweet this
Zhejiang Jolly Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Jolly Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Jolly Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Jolly Pharmaceutical Co Ltd. The current macd is 0.47658305.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jolly Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Jolly Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Jolly Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Jolly Pharmaceutical Co Ltd. The current adx is 34.34.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Jolly Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Zhejiang Jolly Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Jolly Pharmaceutical Co Ltd. The current sar is 12.46.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Jolly Pharmaceutical Co Ltd. The current rsi is 69.85. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Jolly Pharmaceutical Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jolly Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Jolly Pharmaceutical Co Ltd. The current cci is 245.79.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Jolly Pharmaceutical Co Ltd. The current cmo is 46.61.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Jolly Pharmaceutical Co Ltd. The current willr is -6.00858369.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Jolly Pharmaceutical Co Ltd.

Zhejiang Jolly Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Jolly Pharmaceutical Co Ltd. The current atr is 0.55869111.

Zhejiang Jolly Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Jolly Pharmaceutical Co Ltd. The current obv is 511,707,163.

Zhejiang Jolly Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Jolly Pharmaceutical Co Ltd. The current mfi is 77.97.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Jolly Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Jolly Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Jolly Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Zhejiang Jolly Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Jolly Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.847
Ma 20Greater thanMa 5013.028
Ma 50Greater thanMa 10011.749
Ma 100Greater thanMa 20011.122
OpenGreater thanClose13.500
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Jolly Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Jolly Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Jolly Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Jolly Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Jolly Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Jolly Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Jolly Pharmaceutical Co Ltd in your mailbox!